Arachidonic acid (AA), which is liberated from membrane phospholipids by phospholipase A2 (PLA2), is converted to oxidized lipids collectively known as eicosanoids, including prostaglandins and leukotrienes (LT), through the cyclooxygenase (COX) and lipoxygenase (LO) pathways. Because an imbalance in the production of these potent mediators of allergic and inflammatory reactions is known to cause inflammatory diseases, cardiovascular diseases, and cancer, understanding the regulation of eicosanoid biosynthesis is an important step toward the elucidation of the pathogenesis of these serious diseases. It has been well documented that the eicosanoid biosynthetic system offers many important drug targets (e.g., aspirin and other non-steroidal anti-inflammatory drugs targeted to COXs);however, inhibition of an individual component without full understanding of this complex system may cause deleterious side effects, as seen with COX-2 inhibitors such as VIOXX. An important theme derived from our previous studies on PLA2s, including secretory group V PLA2 (gVPLA2) and cytosolic group IVA PLA2 (cPLA21), is that the spatiotemporal coordination of PLA2s and other components of the LT biosynthetic system and the cross-talk among them are important for the control of inflammatory responses. To date, however, no systematic and mechanistic studies on the spatiotemporal coordination of eicosanoid biosynthetic proteins have been reported. During the next grant period, we therefore propose to expand our investigation to other known components of LT biosynthetic system, including 5-lipoxygenase (5LO), 5LO-activating protein (FLAP) and LTC4 synthase (LTC4S). We will first determine the mechanisms underlying the unique and complex membrane binding and cellular dynamics of 5LO. In particular, we will determine how 5LO phosphorylation and AA regulate the membrane interaction, dynamics, and activity of 5LO. We will then elucidate the elusive mechanism by which FLAP regulates the cellular localization and activity of 5LO by dual-color single molecule tracking, fluorescence cross-correlation spectroscopy, and a 5LO cell activity assay. We will also determine how the spatiotemporal dynamics and activities of all potential components of LTC4 biosynthesis are orchestrated in mammalian cells and how modulation of each of these processes affects the LT biosynthesis by the same techniques.

Public Health Relevance

Many inflammatory diseases, including asthma and rheumatoid arthritis, cardiovascular diseases, and cancer, are linked to defects in regulation of eicosanoid biosynthesis. Consequently, eicosanoid biosynthetic pathways are major targets for drug development (for example, aspirin and other non- steroidal anti-inflammatory drugs) but the complexity of these pathways has hampered the discovery of specific and potent drugs with minimal side effects. Therefore, understanding the mechanisms underlying complex eicosanoid biosynthetic pathways will greatly aid in developing new classes of therapeutic agents that can treat diseases caused by dysfunctional eicosanoid biosynthesis. The proposed studies will provide new mechanistic insight into the spatiotemporal coordination of eicosanoid biosynthetic proteins and the cross-talk among them. This timely and critical information will accelerate development and evaluation of new therapeutic agents for inflammatory diseases, cardiovascular diseases, and cancer.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Biochemistry and Biophysics of Membranes Study Section (BBM)
Program Officer
Gerratana, Barbara
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Arts and Sciences
United States
Zip Code
Kim, Hyunjin; Afsari, Hamid Samareh; Cho, Wonhwa (2013) High-throughput fluorescence assay for membrane-protein interaction. J Lipid Res 54:3531-8
Sheng, Ren; Chen, Yong; Yung Gee, Heon et al. (2012) Cholesterol modulates cell signaling and protein networking by specifically interacting with PDZ domain-containing scaffold proteins. Nat Commun 3:1249
McCary, Christine A; Yoon, Youngdae; Panagabko, Candace et al. (2012) Vitamin E isoforms directly bind PKC? and differentially regulate activation of PKC?. Biochem J 441:189-98
Bolger, Joshua K; Tian, Wen; Wolter, William R et al. (2011) Synthesis and evaluation of 5-lipoxygenase translocation inhibitors from acylnitroso hetero-Diels-Alder cycloadducts. Org Biomol Chem 9:2999-3010
Morales, Krystal A; Lasagna, Mauricio; Gribenko, Alexey V et al. (2011) Pb2+ as modulator of protein-membrane interactions. J Am Chem Soc 133:10599-611
Chen, Wei; Goldfine, Howard; Ananthanarayanan, Bharath et al. (2009) Listeria monocytogenes phosphatidylinositol-specific phospholipase C: Kinetic activation and homing in on different interfaces. Biochemistry 48:3578-92
Manna, Debasis; Bhardwaj, Nitin; Vora, Mohsin S et al. (2008) Differential roles of phosphatidylserine, PtdIns(4,5)P2, and PtdIns(3,4,5)P3 in plasma membrane targeting of C2 domains. Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKCalpha C2 domain. J Biol Chem 283:26047-58
Tian, Wen; Wijewickrama, Gihani T; Kim, Jung Hwan et al. (2008) Mechanism of regulation of group IVA phospholipase A2 activity by Ser727 phosphorylation. J Biol Chem 283:3960-71
Bhardwaj, Nitin; Stahelin, Robert V; Zhao, Guijun et al. (2007) MeTaDoR: a comprehensive resource for membrane targeting domains and their host proteins. Bioinformatics 23:3110-2
Stahelin, Robert V; Subramanian, Preeti; Vora, Mohsin et al. (2007) Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain. J Biol Chem 282:20467-74

Showing the most recent 10 out of 70 publications